Role of atrial tissue remodeling on rotor dynamics: an in vitro study

Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1964-73. doi: 10.1152/ajpheart.00055.2015. Epub 2015 Sep 25.

Abstract

The objective of this article is to present an in vitro model of atrial cardiac tissue that could serve to study the mechanisms of remodeling related to atrial fibrillation (AF). We analyze the modification on gene expression and modifications on rotor dynamics following tissue remodeling. Atrial murine cells (HL-1 myocytes) were maintained in culture after the spontaneous initiation of AF and analyzed at two time points: 3.1 ± 1.3 and 9.7 ± 0.5 days after AF initiation. The degree of electrophysiological remodeling (i.e., relative gene expression of key ion channels) and structural inhomogeneity was compared between early and late cell culture times both in nonfibrillating and fibrillating cell cultures. In addition, the electrophysiological characteristics of in vitro fibrillation [e.g., density of phase singularities (PS/cm(2)), dominant frequency, and rotor meandering] analyzed by means of optical mapping were compared with the degree of electrophysiological remodeling. Fibrillating cell cultures showed a differential ion channel gene expression associated with atrial tissue remodeling (i.e., decreased SCN5A, CACN1C, KCND3, and GJA1 and increased KCNJ2) not present in nonfibrillating cell cultures. Also, fibrillatory complexity was increased in late- vs. early stage cultures (1.12 ± 0.14 vs. 0.43 ± 0.19 PS/cm(2), P < 0.01), which was associated with changes in the electrical reentrant patterns (i.e., decrease in rotor tip meandering and increase in wavefront curvature). HL-1 cells can reproduce AF features such as electrophysiological remodeling and an increased complexity of the electrophysiological behavior associated with the fibrillation time that resembles those occurring in patients with chronic AF.

Keywords: atrial fibrillation; optical mapping.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / genetics
  • Atrial Fibrillation / metabolism
  • Atrial Fibrillation / physiopathology*
  • Atrial Remodeling* / drug effects
  • Calcium Channels, L-Type / genetics
  • Calcium Channels, L-Type / metabolism
  • Cell Line
  • Connexin 43 / genetics
  • Connexin 43 / metabolism
  • Gene Expression Regulation
  • Heart Atria / drug effects
  • Heart Atria / metabolism
  • Heart Atria / physiopathology
  • Mice
  • Models, Cardiovascular
  • NAV1.5 Voltage-Gated Sodium Channel / genetics
  • NAV1.5 Voltage-Gated Sodium Channel / metabolism
  • Potassium Channels, Inwardly Rectifying / genetics
  • Potassium Channels, Inwardly Rectifying / metabolism
  • Shal Potassium Channels / genetics
  • Shal Potassium Channels / metabolism
  • Time Factors
  • Voltage-Sensitive Dye Imaging

Substances

  • Anti-Arrhythmia Agents
  • CACNA1C protein, mouse
  • Calcium Channels, L-Type
  • Connexin 43
  • GJA1 protein, mouse
  • Kcnd3 protein, mouse
  • Kir2.1 channel
  • NAV1.5 Voltage-Gated Sodium Channel
  • Potassium Channels, Inwardly Rectifying
  • Scn5a protein, mouse
  • Shal Potassium Channels